Non-motor symptoms in Parkinson's disease

被引:174
作者
Park, Ariane [2 ]
Stacy, Mark [1 ]
机构
[1] Duke Univ, Med Ctr, Div Neurol, Durham, NC 27705 USA
[2] Ohio State Univ, Dept Neurol, Columbus, OH 43210 USA
关键词
Parkinson's disease; Non-motor symptoms; Dopaminergic treatment; SLEEP BEHAVIOR DISORDER; NEUROGENIC ORTHOSTATIC HYPOTENSION; MULTIPLE SYSTEM ATROPHY; LEWY BODY DISEASE; DOUBLE-BLIND; DAYTIME SLEEPINESS; OVERACTIVE BLADDER; COGNITIVE IMPAIRMENT; INDUCED PSYCHOSIS; OPEN-LABEL;
D O I
10.1007/s00415-009-5240-1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Parkinson's disease is a hypokinetic movement disorder with cardinal motor features of bradykinesia, resting tremor and rigidity. However, non-motor symptoms, such as cognitive, neuropsychiatric, sleep, autonomic and sensory disturbances are gaining increasing attention. These non-motor symptoms may be intrinsic to the disease pathology or may be results of treatment with dopaminergic agents. Given that most, if not all, patients with Parkinson's disease will experience non-motor symptoms, it is important to be sensitive to these phenomena, especially since some non-motor signs may precede motor impairment. Treatment may include interventions independent of traditional, dopaminergic anti-Parkinson therapy or may be tailored to increase or reduce dopamine responsiveness of the symptom.
引用
收藏
页码:S293 / S298
页数:6
相关论文
共 58 条
  • [1] Risk of dementia in Parkinson's disease - A community-based, prospective study
    Aarsland, D
    Andersen, K
    Larsen, JP
    Lolk, A
    Nielsen, H
    Kragh-Sorensen, P
    [J]. NEUROLOGY, 2001, 56 (06) : 730 - 736
  • [2] Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study
    Aarsland, D
    Laake, K
    Larsen, JP
    Janvin, C
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2002, 72 (06) : 708 - 712
  • [3] Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease
    Adler, CH
    Caviness, JN
    Hentz, JG
    Lind, M
    Tiede, J
    [J]. MOVEMENT DISORDERS, 2003, 18 (03) : 287 - 293
  • [4] Insights into REM sleep behavior disorder pathophysiology in brainstem-predominant Lewy body disease
    Boeve, B. F.
    Dickson, D. W.
    Olson, E. J.
    Shepard, J. W.
    Silber, M. H.
    Ferman, T. J.
    Ahlskog, J. E.
    Benarroch, E. E.
    [J]. SLEEP MEDICINE, 2007, 8 (01) : 60 - 64
  • [5] Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease - An in vivo positron emission tomographic study
    Bohnen, NI
    Kaufer, DI
    Ivanco, LS
    Lopresti, B
    Koeppe, RA
    Davis, JG
    Mathis, CA
    Moore, RY
    DeKosky, ST
    [J]. ARCHIVES OF NEUROLOGY, 2003, 60 (12) : 1745 - 1748
  • [6] Staging of brain pathology related to sporadic Parkinson's disease
    Braak, H
    Del Tredici, K
    Rüb, U
    de Vos, RAI
    Steur, ENHJ
    Braak, E
    [J]. NEUROBIOLOGY OF AGING, 2003, 24 (02) : 197 - 211
  • [7] Treatment with antiparkinson and antidepressant drugs: A register-based, pharmaco-epidemiological study
    Brandt-Christensen, Mette
    Kvist, Kajsa
    Nilsson, Flemming Morkeberg
    Andersen, Per Kragh
    Kessing, Lars Vedel
    [J]. MOVEMENT DISORDERS, 2007, 22 (14) : 2037 - 2042
  • [8] Olanzapine in the treatment of dopamimetic-induced psychosis in patients with Parkinson's disease
    Breier, A
    Sutton, VK
    Feldman, PD
    Kadam, DL
    Ferchland, I
    Wright, P
    Friedman, JH
    [J]. BIOLOGICAL PSYCHIATRY, 2002, 52 (05) : 438 - 445
  • [9] Recent developments in the management of overactive bladder: focus on the efficacy and tolerability of once daily solifenacin succinate 5 mg
    Brunton, S
    Kuritzky, L
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (01) : 71 - 80
  • [10] Acute vs chronic effects of L-dopa on bladder function in patients with mild Parkinson disease
    Brusa, L.
    Petta, F.
    Pisani, A.
    Moschella, V.
    Iani, C.
    Stanzione, P.
    Miano, R.
    Finazzi-Agro, E.
    [J]. NEUROLOGY, 2007, 68 (18) : 1455 - 1459